OS Therapies
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,437 | -779 | -629 | -1,157 |
EBIT | -779 | -630 | ||
Net Income | -2,875 | -1,557 | -1,458 | -1,464 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,384 | -881 | -641 | -871 |
Cash | 1,858 | 94 | 100 | 38 |
Basic Shares | 15,897 | 20,597 | 20,049 | 20,597 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -4,338 | -4,445 | -4,836 |
EBIT | -4,342 | -4,446 | -4,837 |
Net Income | -7,791 | -6,254 | -7,420 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,006 | -3,792 | -4,414 |
Cash | 38 | 171 | 80 |
Basic Shares | 20,049 | 23,100 | 23,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.07 |
